Psychemedics Announces First Quarter Results
13 mai 2020 17h15 HE
|
Psychemedics Corporation
ACTON, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2020. The Company’s revenue for...
Psychemedics Announces a “Vaping Panel” to Detect and Deter the Use of Marijuana, CBD and Nicotine
05 mai 2020 08h00 HE
|
Psychemedics Corporation
ACTON, Mass., May 05, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced a Vaping Panel to...
Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA
29 avr. 2020 12h00 HE
|
Psychemedics Corporation
ACTON, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the first...
Psychemedics Corporation to Webcast 2020 Annual Meeting of Stockholders
28 avr. 2020 14h00 HE
|
Psychemedics Corporation
ACTON, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) will hold its Annual Meeting of Stockholders (“Annual Meeting”) on Thursday, May 14, 2020 at 2:00 p.m. ET. The...
Psychemedics Corporation Announces 4th Quarter and Year-End Results
11 févr. 2020 17h25 HE
|
Psychemedics Corporation
ACTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2019. The...
Psychemedics Corporation Responds to Court Decision
31 oct. 2019 12h07 HE
|
Psychemedics Corporation
ACTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today issued a response to a Massachusetts Supreme Judicial Court ruling in the case of Boston Police Department...
Psychemedics Announces Third Quarter Results and Declares 93rd Consecutive Quarterly Dividend
22 oct. 2019 17h25 HE
|
Psychemedics Corporation
ACTON, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2019. The Company also...
Psychemedics Corporation Announces New Brazilian Distribution Agreement
19 sept. 2019 17h25 HE
|
Psychemedics Corporation
ACTON, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq:PMD) announced today that it has entered into a new distribution agreement in Brazil with Sansão Holding S.A. and...
Psychemedics Announces Second Quarter Results and Declares 92nd Consecutive Quarterly Dividend
23 juil. 2019 17h25 HE
|
Psychemedics Corporation
ACTON, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2019. The Company also announced...
Psychemedics Test for Fentanyl Detection Cleared by FDA
24 avr. 2019 08h00 HE
|
Psychemedics Corporation
ACTON, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the industry’s...